chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: M
Vaccine: HEPAB, IPV, MEN, TD, YF, HEPAB, IPV, MEN, TD, YF
Symptoms: Chromaturia, Dyspnoea, Enzyme abnormality, Headache, Leukopenia
Clinical narrative: It was reported that a 22 year old male college student received YF-VAX on 7/9/03. The lot number and route/site were not reported. Two days post-vaccination, the pt began not feeling well and developed a fever. A couple days later his urine became dark, he was nauseous and had diarrhea. The pt went back to the clinic and the physician there contacted the CDC. It was decided to hospitalize him immediately and start him on intravenous immunoglobulin treatment. Lab tests showed elevated liver function tests, AST 583, alkaline phosphatase 159, albumin 768 and platelets 74. As of 7/15/03, his platelets have dropped to 69. A telephone call was received on 7/16/03 from the responsible physician. She reported that the lot number for YF-VAX is UB362AA. The pt was hospitalized on 7/15/03. The physician stated that she reported this to the CDC. No additional info was provided.  A 15-day follow up report received 7/31/2003 adds: From additional info received on 07/17/2003, it was reported that the pt began experiencing a fever and headaches 2 days after vaccination. Over the next few days, he had body aches, orange urine, nausea, sore throat, congestion and shortness of breath. The pt was hospitalized on 07/14/2003. It was reported that the correct date of vaccination was 07/08/2003 in the AM and that in addition to YF-VAX, the pt also received IPOL, Lot #W0816, administered subcutaneously in the right arm, MENOMUNE, Lot #UB448AA, administered subcutaneously in the left arm, TD ADS ADULT, Lot #U0840AA, administered intra-muscularly in the left arm, and TWINRIX, Lot #HAB238B6 (GlaxoSmithKline), administered intra-muscularly in the right arm. Other additional info provided includes the pt's identity and date of birth, corrections to vaccination and onset dates, length of hospitalization, and pt history. The pt had a positive Polymerace Chain Reaction for Epstein Barr Virus and positive mono spot. No relevant history except for consumption of alcohol the evening prior to the onset of symptoms. He has been discharged from the hospital but his labs are still abnormal. Specimens have been sent for analysis. Reportedly, the pt has not recovered from this event. From additional info received on 07/24/2003, from a telephone call with the reporter, liver function tests are back to normal. No viremia detected in tissue samples on day 6. A 15-day follow up report received 10/20/2003 adds: From additional info received on 10/08/2003, it was reported that regarding this pt with a concurrent Epstein-Barr Virus Infection, the lab testing was completed. Findings are provided in the section "Relevant Diagnostic tests/Laboratory data". Reportedly, the pt was going to a foreign country for 6 months. The CDC will get follow-up serum from the pt during his trip. "The pt is protected from yellow fever infection, he was boosted prior to departure." 08Mar04: No additional information was received from the CDC. This case is considered closed.
Age: 22.0
Sex: M
Vaccine: HEPAB, IPV, MEN, TD, YF, HEPAB, IPV, MEN, TD, YF
Symptoms: Liver function test abnormal, Nasal congestion, Nausea, Pain, Pharyngolaryngeal pain
Clinical narrative: It was reported that a 22 year old male college student received YF-VAX on 7/9/03. The lot number and route/site were not reported. Two days post-vaccination, the pt began not feeling well and developed a fever. A couple days later his urine became dark, he was nauseous and had diarrhea. The pt went back to the clinic and the physician there contacted the CDC. It was decided to hospitalize him immediately and start him on intravenous immunoglobulin treatment. Lab tests showed elevated liver function tests, AST 583, alkaline phosphatase 159, albumin 768 and platelets 74. As of 7/15/03, his platelets have dropped to 69. A telephone call was received on 7/16/03 from the responsible physician. She reported that the lot number for YF-VAX is UB362AA. The pt was hospitalized on 7/15/03. The physician stated that she reported this to the CDC. No additional info was provided.  A 15-day follow up report received 7/31/2003 adds: From additional info received on 07/17/2003, it was reported that the pt began experiencing a fever and headaches 2 days after vaccination. Over the next few days, he had body aches, orange urine, nausea, sore throat, congestion and shortness of breath. The pt was hospitalized on 07/14/2003. It was reported that the correct date of vaccination was 07/08/2003 in the AM and that in addition to YF-VAX, the pt also received IPOL, Lot #W0816, administered subcutaneously in the right arm, MENOMUNE, Lot #UB448AA, administered subcutaneously in the left arm, TD ADS ADULT, Lot #U0840AA, administered intra-muscularly in the left arm, and TWINRIX, Lot #HAB238B6 (GlaxoSmithKline), administered intra-muscularly in the right arm. Other additional info provided includes the pt's identity and date of birth, corrections to vaccination and onset dates, length of hospitalization, and pt history. The pt had a positive Polymerace Chain Reaction for Epstein Barr Virus and positive mono spot. No relevant history except for consumption of alcohol the evening prior to the onset of symptoms. He has been discharged from the hospital but his labs are still abnormal. Specimens have been sent for analysis. Reportedly, the pt has not recovered from this event. From additional info received on 07/24/2003, from a telephone call with the reporter, liver function tests are back to normal. No viremia detected in tissue samples on day 6. A 15-day follow up report received 10/20/2003 adds: From additional info received on 10/08/2003, it was reported that regarding this pt with a concurrent Epstein-Barr Virus Infection, the lab testing was completed. Findings are provided in the section "Relevant Diagnostic tests/Laboratory data". Reportedly, the pt was going to a foreign country for 6 months. The CDC will get follow-up serum from the pt during his trip. "The pt is protected from yellow fever infection, he was boosted prior to departure." 08Mar04: No additional information was received from the CDC. This case is considered closed.
Age: 22.0
Sex: M
Vaccine: HEPAB, IPV, MEN, TD, YF, HEPAB, IPV, MEN, TD, YF
Symptoms: Platelet count decreased, Pyrexia, Thrombocytopenia, White blood cell count decreased
Clinical narrative: It was reported that a 22 year old male college student received YF-VAX on 7/9/03. The lot number and route/site were not reported. Two days post-vaccination, the pt began not feeling well and developed a fever. A couple days later his urine became dark, he was nauseous and had diarrhea. The pt went back to the clinic and the physician there contacted the CDC. It was decided to hospitalize him immediately and start him on intravenous immunoglobulin treatment. Lab tests showed elevated liver function tests, AST 583, alkaline phosphatase 159, albumin 768 and platelets 74. As of 7/15/03, his platelets have dropped to 69. A telephone call was received on 7/16/03 from the responsible physician. She reported that the lot number for YF-VAX is UB362AA. The pt was hospitalized on 7/15/03. The physician stated that she reported this to the CDC. No additional info was provided.  A 15-day follow up report received 7/31/2003 adds: From additional info received on 07/17/2003, it was reported that the pt began experiencing a fever and headaches 2 days after vaccination. Over the next few days, he had body aches, orange urine, nausea, sore throat, congestion and shortness of breath. The pt was hospitalized on 07/14/2003. It was reported that the correct date of vaccination was 07/08/2003 in the AM and that in addition to YF-VAX, the pt also received IPOL, Lot #W0816, administered subcutaneously in the right arm, MENOMUNE, Lot #UB448AA, administered subcutaneously in the left arm, TD ADS ADULT, Lot #U0840AA, administered intra-muscularly in the left arm, and TWINRIX, Lot #HAB238B6 (GlaxoSmithKline), administered intra-muscularly in the right arm. Other additional info provided includes the pt's identity and date of birth, corrections to vaccination and onset dates, length of hospitalization, and pt history. The pt had a positive Polymerace Chain Reaction for Epstein Barr Virus and positive mono spot. No relevant history except for consumption of alcohol the evening prior to the onset of symptoms. He has been discharged from the hospital but his labs are still abnormal. Specimens have been sent for analysis. Reportedly, the pt has not recovered from this event. From additional info received on 07/24/2003, from a telephone call with the reporter, liver function tests are back to normal. No viremia detected in tissue samples on day 6. A 15-day follow up report received 10/20/2003 adds: From additional info received on 10/08/2003, it was reported that regarding this pt with a concurrent Epstein-Barr Virus Infection, the lab testing was completed. Findings are provided in the section "Relevant Diagnostic tests/Laboratory data". Reportedly, the pt was going to a foreign country for 6 months. The CDC will get follow-up serum from the pt during his trip. "The pt is protected from yellow fever infection, he was boosted prior to departure." 08Mar04: No additional information was received from the CDC. This case is considered closed.
Age: 22.0
Sex: M
Vaccine: HEPAB, IPV, MEN, TD, YF, HEPAB, IPV, MEN, TD, YF
Symptoms: Alanine aminotransferase increased, Blood alkaline phosphatase increased, Chromaturia, Diarrhoea, Liver function test abnormal
Clinical narrative: It was reported that a 22 year old male college student received YF-VAX on 7/9/03. The lot number and route/site were not reported. Two days post-vaccination, the pt began not feeling well and developed a fever. A couple days later his urine became dark, he was nauseous and had diarrhea. The pt went back to the clinic and the physician there contacted the CDC. It was decided to hospitalize him immediately and start him on intravenous immunoglobulin treatment. Lab tests showed elevated liver function tests, AST 583, alkaline phosphatase 159, albumin 768 and platelets 74. As of 7/15/03, his platelets have dropped to 69. A telephone call was received on 7/16/03 from the responsible physician. She reported that the lot number for YF-VAX is UB362AA. The pt was hospitalized on 7/15/03. The physician stated that she reported this to the CDC. No additional info was provided.  A 15-day follow up report received 7/31/2003 adds: From additional info received on 07/17/2003, it was reported that the pt began experiencing a fever and headaches 2 days after vaccination. Over the next few days, he had body aches, orange urine, nausea, sore throat, congestion and shortness of breath. The pt was hospitalized on 07/14/2003. It was reported that the correct date of vaccination was 07/08/2003 in the AM and that in addition to YF-VAX, the pt also received IPOL, Lot #W0816, administered subcutaneously in the right arm, MENOMUNE, Lot #UB448AA, administered subcutaneously in the left arm, TD ADS ADULT, Lot #U0840AA, administered intra-muscularly in the left arm, and TWINRIX, Lot #HAB238B6 (GlaxoSmithKline), administered intra-muscularly in the right arm. Other additional info provided includes the pt's identity and date of birth, corrections to vaccination and onset dates, length of hospitalization, and pt history. The pt had a positive Polymerace Chain Reaction for Epstein Barr Virus and positive mono spot. No relevant history except for consumption of alcohol the evening prior to the onset of symptoms. He has been discharged from the hospital but his labs are still abnormal. Specimens have been sent for analysis. Reportedly, the pt has not recovered from this event. From additional info received on 07/24/2003, from a telephone call with the reporter, liver function tests are back to normal. No viremia detected in tissue samples on day 6. A 15-day follow up report received 10/20/2003 adds: From additional info received on 10/08/2003, it was reported that regarding this pt with a concurrent Epstein-Barr Virus Infection, the lab testing was completed. Findings are provided in the section "Relevant Diagnostic tests/Laboratory data". Reportedly, the pt was going to a foreign country for 6 months. The CDC will get follow-up serum from the pt during his trip. "The pt is protected from yellow fever infection, he was boosted prior to departure." 08Mar04: No additional information was received from the CDC. This case is considered closed.
Age: 22.0
Sex: M
Vaccine: HEPAB, IPV, MEN, TD, YF, HEPAB, IPV, MEN, TD, YF
Symptoms: Malaise, Nausea, Pyrexia, Thrombocytopenia
Clinical narrative: It was reported that a 22 year old male college student received YF-VAX on 7/9/03. The lot number and route/site were not reported. Two days post-vaccination, the pt began not feeling well and developed a fever. A couple days later his urine became dark, he was nauseous and had diarrhea. The pt went back to the clinic and the physician there contacted the CDC. It was decided to hospitalize him immediately and start him on intravenous immunoglobulin treatment. Lab tests showed elevated liver function tests, AST 583, alkaline phosphatase 159, albumin 768 and platelets 74. As of 7/15/03, his platelets have dropped to 69. A telephone call was received on 7/16/03 from the responsible physician. She reported that the lot number for YF-VAX is UB362AA. The pt was hospitalized on 7/15/03. The physician stated that she reported this to the CDC. No additional info was provided.  A 15-day follow up report received 7/31/2003 adds: From additional info received on 07/17/2003, it was reported that the pt began experiencing a fever and headaches 2 days after vaccination. Over the next few days, he had body aches, orange urine, nausea, sore throat, congestion and shortness of breath. The pt was hospitalized on 07/14/2003. It was reported that the correct date of vaccination was 07/08/2003 in the AM and that in addition to YF-VAX, the pt also received IPOL, Lot #W0816, administered subcutaneously in the right arm, MENOMUNE, Lot #UB448AA, administered subcutaneously in the left arm, TD ADS ADULT, Lot #U0840AA, administered intra-muscularly in the left arm, and TWINRIX, Lot #HAB238B6 (GlaxoSmithKline), administered intra-muscularly in the right arm. Other additional info provided includes the pt's identity and date of birth, corrections to vaccination and onset dates, length of hospitalization, and pt history. The pt had a positive Polymerace Chain Reaction for Epstein Barr Virus and positive mono spot. No relevant history except for consumption of alcohol the evening prior to the onset of symptoms. He has been discharged from the hospital but his labs are still abnormal. Specimens have been sent for analysis. Reportedly, the pt has not recovered from this event. From additional info received on 07/24/2003, from a telephone call with the reporter, liver function tests are back to normal. No viremia detected in tissue samples on day 6. A 15-day follow up report received 10/20/2003 adds: From additional info received on 10/08/2003, it was reported that regarding this pt with a concurrent Epstein-Barr Virus Infection, the lab testing was completed. Findings are provided in the section "Relevant Diagnostic tests/Laboratory data". Reportedly, the pt was going to a foreign country for 6 months. The CDC will get follow-up serum from the pt during his trip. "The pt is protected from yellow fever infection, he was boosted prior to departure." 08Mar04: No additional information was received from the CDC. This case is considered closed.
Age: 0.35
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Pyrexia, Sepsis, Tremor, Vaccination complication
Clinical narrative: Pt was seen at ER approximately 48 hrs after getting vaccines with fever 103.4. Parents also noticed infant "shaking." Was hospitalized at hospital. Medical Records received on 10/09/2003 states bacteremia and vaccine reaction.
Age: 67.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Balance disorder, Clumsiness, Fatigue, Hypoaesthesia
Clinical narrative: Numbness in hands and feet ankle and joint pain and tingling in toes neck pain and stiffness eye sight problems fatigue rash nightsweats nightmares balance and clumsy ? ear ringing and buzzing.
Age: 67.0
Sex: M
Vaccine: LYME
Symptoms: Laboratory test abnormal, Musculoskeletal stiffness, Neck pain, Night sweats, Nightmare
Clinical narrative: Numbness in hands and feet ankle and joint pain and tingling in toes neck pain and stiffness eye sight problems fatigue rash nightsweats nightmares balance and clumsy ? ear ringing and buzzing.
Age: 67.0
Sex: M
Vaccine: LYME
Symptoms: Paraesthesia, Rash, Tinnitus, Visual disturbance
Clinical narrative: Numbness in hands and feet ankle and joint pain and tingling in toes neck pain and stiffness eye sight problems fatigue rash nightsweats nightmares balance and clumsy ? ear ringing and buzzing.
Age: 0.6
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Decreased appetite, Dehydration, Laboratory test abnormal, Oliguria, Pyrexia
Clinical narrative: Very high fever-(mom did not have thermometer), decreased po intake, decreased urination x 2 d, requiring hospitalization secondary to dehydration.
Age: 0.6
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Decreased appetite, Dehydration, Pyrexia
Clinical narrative: Very high fever-(mom did not have thermometer), decreased po intake, decreased urination x 2 d, requiring hospitalization secondary to dehydration.
Sex: M
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: A male consumer reported that he received an injection of Flu Shield (influenza virus vaccine, trivalent, types A & B) (1996-1997 formula) (manufacturer unknown) in November 1996.  48 hours post-immunization, he developed a rash on "numerous parts of his body".  The patient's physician prescribed a three week tapering dose of prednisone.  The patient indicated that he developes the "rash five times a year and is treated with prednisone."  No further information was availabe at the date of this report.
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Vomiting
Clinical narrative: Follow up information received on 05/09/2003 from the physician previously reported as the vaccine provider indicated that the patient did not receive a flu vaccine from this facility.  A medical assistant reported that a 67 year old female received a flu vaccine (manufacturer unknown) "earlier this year" and experienced nausea and vomiting post-vaccination.
Age: 33.0
Sex: M
Vaccine: ANTH
Symptoms: Muscular weakness
Clinical narrative: Onset of weakness left shoulder approx 4 days after receipt of AVA booster SC in skin over right deltoid. Pt reported to clinic on 07/01/03. Examination revealed 4+15 weakness of abduction at 45 degrees of right shoulder extension. No sensory loss. DTRs normal. Plantars, no tingling, numbness. Spine WNL.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Pain
Clinical narrative: Left upper arm pain after receiving Anthrax series #1 and #2 - got significantly worse after second shot and has never gone away. 4 months have past since last shot.
Age: 41.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Oedema
Clinical narrative: Swelling in left breast area after approx 2 weeks.
Age: 44.0
Sex: F
Vaccine: ANTH, TYP
Symptoms: Injection site mass, Tenderness
Clinical narrative: Tenderness and 1-2 cm round nodule at Anthrax vaccination site.
Age: 36.0
Sex: F
Vaccine: TTOX
Symptoms: Feeling hot, Injection site erythema, Pain in jaw, Polyarthritis
Clinical narrative: Two days after tetanus vaccine, pt developed polyarthritis, jaw stiffness, with redness and warmth at the injection site. Polyarthritis has persisted until now and pt is currently on methotrexate.
Age: 2.5
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pyrexia
Clinical narrative: On the 8th and 9th day after vaccinations, high fever ranging from 102-103 degrees. Same exact symptoms and timing as fraternal twin brother-vaccines were 2 weeks apart!
Age: 2.5
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pyrexia
Clinical narrative: On the 8th and 9th day after vaccinations, high fevers ranging 102-103 degrees. Same exact symptoms as fraternal twin brother-2 weeks apart.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Chest discomfort, Dyspnoea, Wheezing
Clinical narrative: 15 minutes after giving VZV pt became SOB. She also had a large local reaction 5", chest had tightness and bilateral wheezings. Epi given and nebulizer albuterol. Pt improved. Pt has exercise induced asthma.
Age: 1.0
Sex: F
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site oedema
Clinical narrative: Left thigh reddened, swollen/firm about 4 1/4". Tylenol and cool compress.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site oedema, Pyrexia
Clinical narrative: Right arm swollen, hard, reddened area about 4", fever 100.1. Rx with Tylenol and cool water soak at home.
Age: 13.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Blister, Lethargy, Pyrexia
Clinical narrative: Hep A #1 and Varicella given on 6/12/03. By 6/30/03 pt sent home for lethargy and fever. On 7/3/03 pt break out with blisters all over the body. Mom advised to use Calamine lotion over blisters, Tylenol prn, no ASA, Benadryl 25 mg every 12 hours prn for itching. RTN if not better.
Age: 3.0
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Redness, swelling in site. Ice pack and Motrin.
Age: 13.0
Sex: M
Vaccine: HEP
Symptoms: Cough, Fatigue, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: Had cold when came in for 3rd hep B 6/26/03 - developed more cough, sore throat, fever the night of 6/28 with shaking chills, now tired (exhausted), occ. parox. cough, very sore throat when coughs, says got a cold about 1 week after receiving 2nd hep B. Referred to clinic for follow up.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Pruritus, Urticaria
Clinical narrative: Urticaria on body - no difficulty breathing - no swelling. Pt complained of itching.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Feeling hot, Injection site erythema, Skin ulcer
Clinical narrative: Vaccines 7/15/03. 7/16/03: Phone report left upper arm with redness and warm to the touch, afebrile. 7/17/03: Seen in office-left arm 7.5 x 4.5 cm red, firm lesion, reaction to DTaP? Ice arm, call back if symptoms persist.
Age: 11.0
Sex: M
Vaccine: TD
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Localized reaction in deltoid area with swelling and redness. Onset-immediately.
Age: 42.0
Sex: F
Vaccine: TD
Symptoms: Injection site oedema, Pain, Urticaria
Clinical narrative: Pt received a dT immunization in her right deltoid on 5/31/03. She returned on 6/4/03 complaining to right arm pain after immunization. Symptoms include a very painful, slightly swollen right arm. She states the pain radiates down into her lower arm. Treatment -pt was prescribed a sling for her arm and anti-inflammatory. She has an appointment with her referral physician on 6/5/03. Pt returned to the ED on 6/13/03 complaining of hives that started on the face. She does have a history of intermittent urticaria and is seen by an allergist. Pt also complains of continued pain in the right upper extremity. She was treated for the allergic reaction with epinephrine, Benadryl, Tagamet and Prednisone. Pain from right arm appears to be coming from the right trapezius. Pt is to follow-up with primary care physician within 2 weeks, see her allergist on 6/16/03 as scheduled and follow-up with the orthopedist within 4 weeks. Warm soaks are prescribed for the shoulder pain. A prescription for Flexeril was given. She may use over the counter Tagamet and Benadryl as needed.
Age: 1.25
Sex: M
Vaccine: DTAP, MMR
Symptoms: Oedema
Clinical narrative: Given shots at 1:30, by 2:00 face and ears swollen. Pt given 1/2 tsp Zyrtec syrup daily for 5 days.
Sex: F
Vaccine: PPV
Symptoms: Injection site oedema, Pruritus
Clinical narrative: Patient had swelling in left upper arm with some itching.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot, Oedema
Clinical narrative: Left upper leg red, swollen, warm to touch.  Patient had no complaints of tenderness or pain.  Tylenol used to treat patient.
Age: 0.4
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Crying, Irritability, Pyrexia, Rash papular
Clinical narrative: Within 5 minutes of receiving immunizations (DTaP/IPV/HIB/PREVNAR); started crying/irritable, fell asleep x 1/2 hour.  20 minutes later had pink papular rash over body.  Hurts on right leg.  Temperature 99 F.  NOTE:  These 3 cases were called to state epidemiologist who seemed disinterested that we had 3 adverse reactions in 1 week in our practice.
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: High-pitched crying, Irritability, Pyrexia, Screaming
Clinical narrative: Given (DTAP/IPV/HIB/PREVNAR) (1st set of vaccines).  Within 2 hours of getting above, patient very irritable with high pitched continuous crying (13 hours).  Sent to ER.  Temperature: 99F.
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Agitation, Screaming
Clinical narrative: Give 4 immunizations around 10:00 within 1/2 hour after leaving office, baby started crying continously-unconsolable.  Temperature: 98.4F.
Age: 5.1
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Injection site induration, Pyrexia
Clinical narrative: 4-5 cm area erythema and induration, left anterior thigh.  Temperature 98.9F.
Age: 42.0
Sex: F
Vaccine: HEPA, TD, TYP
Symptoms: Arthralgia, Oedema
Clinical narrative: Swollen, painful knees, discomfort in ankles and wrists.  Started 24 hours after injections and lasted 10 days.
Age: 1.6
Sex: F
Vaccine: DTAP, MMR
Symptoms: Feeling hot, Injection site erythema, Injection site induration, Injection site oedema
Clinical narrative: 07/15/2003: Patient vaccinated with DTaP to left thigh.  Developed swelling, redness, induration, warmth about 11 hours later.  Patient always able to walk with limp and non-tender swelling.
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Feeling hot, Oedema
Clinical narrative: Left thigh became very big with redness from "hip joint to knee" per mom-warm to touch.
Age: 11.0
Sex: F
Vaccine: HEP, HEPA, TD
Symptoms: Rash
Clinical narrative: Developed rash.
Age: 56.0
Sex: F
Vaccine: RUB
Symptoms: Arthralgia, Oedema, Photophobia, Rash macular, Rash pruritic
Clinical narrative: 07/15/2003: Photophobia; 07/16/2003: Macular pruritic rash; arthralgia right knee and right index finger; edema right index finger.
Age: 4.7
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Oedema
Clinical narrative: Edema & erythema of left deltoid region on 07/15/2003.  Was slowly getting better on 07/16/2003 when patient was seen.
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia, Vomiting
Clinical narrative: Fever up to 103-101 x 3 days.  Vomiting x 1 day.  Went to ER at 06/07/2003.  Seen in office 06/09/2003: Ok.
Age: 1.8
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Injection site induration, Rash macular
Clinical narrative: Induration at vaccine site <1cm, excoriated, red, macule on leg.  Right thigh.  Seen 07/15/2003: given 1% HC creme to be used at affected area twice daily.
Age: 5.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Erythema
Clinical narrative: Child presented to our office on 07/11/2003 with erythemous area over medial aspect of left arm.  No other symptoms expressed by mother.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Erythema, Injection site induration, Vomiting
Clinical narrative: Child presented in our office 07/11/2003 with erythema to left medial thigh (1/5 x 1 in ) firm, but not tender.  child also with some vomiting per mother.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Mother states she noticed redness and swelling this AM 07/17/2003.  Left arm (70mmx 70mm).  Mother using cold compresses at site.  Denies any other symptoms.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot, Injection site oedema
Clinical narrative: Erythematous swelling around the site (DTAP/IPV), warm to touch, but non-tender, 5 inches by 3 3/4 inches.
Age: 55.0
Sex: F
Vaccine: TD
Symptoms: Erythema, Nausea, Oedema, Pain
Clinical narrative: Patient complained of sick to stomach arm swollen and red in 3-4 different areas.  Tender under arm.
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Dyskinesia
Clinical narrative: Symetrical jerking movements off and on for 2 hours.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Pt received DTaP, IPV, MMR. Next day had local reaction to DTaP-swelling and redness in arm.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Pyrexia
Clinical narrative: Mom called 1 week after varivax and said child had a low grade fever for a day or two, then broke out with red areas all over body.  some hove blisters estimated 250 areas - child not ill, playing.  Nurse at District Office told mom it was chickenpox, unknown if child was exposed to CP before shot - is in daycare, mom had copy of VIS re-rash and fever.
Age: 3.0
Sex: M
Vaccine: DTAP, HIBV, IPV, MMR
Symptoms: Erythema, Feeling hot, Oedema
Clinical narrative: Red/Swelling/hot to touch right anterior leg - size of jar lid & about 2" above knee - child walking & not complaining.
Age: 30.0
Sex: M
Vaccine: ANTH, SMALL, SMALL
Symptoms: Malaise, Myalgia, Pyrexia, Rash erythematous, Rash pruritic
Clinical narrative: Member received anthrax#1 and smallpox vaccine on 11 July 2003 (first time vaccinee against smallpox).  On 20 July member noticed an itchy erythematous pustular rash on trunk and developed worsening myalgias/malaise/subjective fevers.  Saw doctor on 21 July 2003 and then presented yesterday to me with a worsening rash involving significant portions of his trunk/upper extremities/neck.  He has no facial involvement and has scattered lesions on his lower extremities.  There is no oropharyngeal or ocular involvement.  Photos were taken and transmitted via email.  They were shown to doctor who feels that this rash is consistent with "nonviral pustulosis" which tends to occur in healthy young males in their 20's.  Treatment is supportive and antihistamines are recommended for itching.  No bloodwork was recommended at this time.  Will continue to observe.  Pt is very well appearing and nontoxic.
Age: 30.0
Sex: M
Vaccine: ANTH, SMALL, SMALL
Symptoms: Rash pustular, Skin ulcer
Clinical narrative: Member received anthrax#1 and smallpox vaccine on 11 July 2003 (first time vaccinee against smallpox).  On 20 July member noticed an itchy erythematous pustular rash on trunk and developed worsening myalgias/malaise/subjective fevers.  Saw doctor on 21 July 2003 and then presented yesterday to me with a worsening rash involving significant portions of his trunk/upper extremities/neck.  He has no facial involvement and has scattered lesions on his lower extremities.  There is no oropharyngeal or ocular involvement.  Photos were taken and transmitted via email.  They were shown to doctor who feels that this rash is consistent with "nonviral pustulosis" which tends to occur in healthy young males in their 20's.  Treatment is supportive and antihistamines are recommended for itching.  No bloodwork was recommended at this time.  Will continue to observe.  Pt is very well appearing and nontoxic.
Age: 30.0
Sex: M
Vaccine: ANTH, SMALL, SMALL
Symptoms: Erythema, Pruritus, Rash vesicular, Skin ulcer
Clinical narrative: Member received anthrax#1 and smallpox vaccine on 11 July 2003 (first time vaccinee against smallpox).  On 20 July member noticed an itchy erythematous pustular rash on trunk and developed worsening myalgias/malaise/subjective fevers.  Saw doctor on 21 July 2003 and then presented yesterday to me with a worsening rash involving significant portions of his trunk/upper extremities/neck.  He has no facial involvement and has scattered lesions on his lower extremities.  There is no oropharyngeal or ocular involvement.  Photos were taken and transmitted via email.  They were shown to doctor who feels that this rash is consistent with "nonviral pustulosis" which tends to occur in healthy young males in their 20's.  Treatment is supportive and antihistamines are recommended for itching.  No bloodwork was recommended at this time.  Will continue to observe.  Pt is very well appearing and nontoxic.
Age: 1.02
Sex: F
Vaccine: DTAP, HIBV, MMR, PNC
Symptoms: Febrile convulsion, Viral infection
Clinical narrative: complex febrile seizure. Discharge Summary received on 9/10/2003 states viral illness.
Age: 23.0
Sex: F
Vaccine: ANTH
Symptoms: Dyspnoea, Flushing, Paraesthesia, Pruritus, Tachycardia
Clinical narrative: Itchy throat 15 mins after receiving 3rd Anthrax shot. Pt c/o tingling and itching in throat and SOB s/p Anthrax immunization. She states she had similar, very slight sx's post 2nd Anthrax imms, but dismissed it. Given Epinephrine inj. immediately post start of sx's. Pt was having none of the above sx's within 15 mins of epi administration. Currently c/o feeling "flushed." CV mild tachycardia. Possible anaphylaxis to Anthrax 3rd injection. Pt released post monitoring for 2 hrs without sx's. Instructed to return or go to ER if sx's rreturns orr prn. No more Anthrax imms for this pt.
Age: 48.0
Sex: M
Vaccine: SMALL
Symptoms: Diarrhoea, Headache, Injection site erythema, Injection site vesicles, Pruritus
Clinical narrative: Urticarial and papular eruption of neck and extremities. Itchy, reddish blister at vaccination site. Several bouts of watery diarrhea, dull headache.
Age: 48.0
Sex: M
Vaccine: SMALL
Symptoms: Rash papular, Urticaria
Clinical narrative: Urticarial and papular eruption of neck and extremities. Itchy, reddish blister at vaccination site. Several bouts of watery diarrhea, dull headache.
Age: 20.0
Sex: F
Vaccine: ANTH, SMALL
Symptoms: Injection site erythema, Injection site oedema, Injection site vesicles, Pain
Clinical narrative: Received vaccine 9 days ago. Developed redness/swelling/tenderness at right upper arm. No fever, no chills. Also complained of tenderness and redness at right axillary lymph node. Right upper arm 5 x 5cm oval, tender erythema surrounding small pox vesicle. Right axillary-small lymph node and enlargement with erythema. Keflex 250 mg po QID, ice, Motrin as needed.
Age: 20.0
Sex: F
Vaccine: SMALL
Symptoms: Unevaluable event
Clinical narrative: Pt received small pox vaccine when approx one week pregnant.
Age: 40.0
Sex: M
Vaccine: SMALL
Symptoms: Headache, Post vaccination autoinoculation, Skin ulcer
Clinical narrative: Developed 20 x 25 cm pruritic lesion on right temple 40 hours after receiving smallpox vaccine autoinoculation. Complained of headache also. ESR 5. Will continue to watch. 7/21/03 - lesion has not yet resolved.
Age: 1.0
Sex: F
Vaccine: HBHEPB, MMR, PNC, VARCEL
Symptoms: Urticaria
Clinical narrative: Varicella Urticaria.
Age: 54.0
Sex: F
Vaccine: SMALL
Symptoms: Blood cholesterol increased, Blood pressure increased, Dyspnoea, Injection site pain, Pain
Clinical narrative: Vaccinated 2/25/03 in Left arm. Had major reaction with take with lymph pain in R and L axillas, 10 days post vaccination. This subsided a few days later. Scab separated at day 19 post vaccination. Pt experienced shooting pains from site before scab separated. About 2-3 weeks post vaccination the pt. noticed significant shorness of breath with stair climbing. Did not seek medical attention because has a history of SOB, however not to this degree. Pt still reports some SOB, though much improved. Has appointment to see MD on August 15. Has 3 cardiac risk factors: elevated blood pressure, elevated cholesterol, and father had heart attack at 50.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Dyspnoea, Electrocardiogram abnormal
Clinical narrative: Smallpox vaccine was administered on 3/14/2003. Approximately 2 weeks later developed SOB with activity. Seen in employee health, by own PCP, and by cardiologist. Chest xray, echo, and stress test negative. Had abnormal T waves on EKG which resolved on follow up. Pt was found via active surveillance.
Age: 31.0
Sex: F
Vaccine: VARCEL
Symptoms: Fatigue, Pyrexia, Rash pruritic, Rash vesicular
Clinical narrative: Patient came to my office 13 days after receiving varicella at a clinic.  She developed a pruritic rash 3 days prior to seeing me.  Also fatigue, low grade temps at home.  Rash was vesicular in appearance - total of 5 lesions the majority on her torso. Pruritic
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Cow pox, Rash pruritic
Clinical narrative: Developed maculo-papular pruritic reaction multiple parts of body which is resistant to tx and flares with menstrual cycle.  Follow up on 12/05/03: "Eleven months after receiving the SP vaccine she continues to have intermittent outbreaks of pruritic discreet lesions mainly on the insides of legs.  The outbreaks no longer coincide with menstrual cycles.  No previous skin disorders."
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Pruritus, Rash maculo-papular
Clinical narrative: Developed maculo-papular pruritic reaction multiple parts of body which is resistant to tx and flares with menstrual cycle.  Follow up on 12/05/03: "Eleven months after receiving the SP vaccine she continues to have intermittent outbreaks of pruritic discreet lesions mainly on the insides of legs.  The outbreaks no longer coincide with menstrual cycles.  No previous skin disorders."
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Anorexia, Cyanosis, Dehydration, Diarrhoea, Gastroenteritis
Clinical narrative: This case described the occurrence of vomiting in a 2 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine for prophylaxis. This report was received from the patient's mother and has not been verified by a physician or other health care professional. On 11/1/02, the patient received the 1st doses of diphtheria and tetanus toxoids and acellular pertussis vaccine, hepatitis B vaccine, 7-valent pneumococcal conjugate vaccine, Haemophilus influenzae type B conjugate vaccine, and inactivated poliomyelitis virus vaccine. On 11/2/02, one day post immunization, the patient experienced heavy vomiting with the inability to keep down fluids, lethargy, diarrhea and heavy urination. The patient was hospitalized for 7 days. The events resolved. The mother reported that the patient's physician considered the events to be caused by pertussis vaccine, and the partussis immunization series was discontinued. A 15-day follow report received 9/5/2003 adds: From additional correspondence received on 08/25/2003, the manufacturer ID number was provided (WAES0307USA03642). The pt's age was reported as 57 days. No new medically significant info was provided.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Insomnia, Lethargy, Somnolence, Vomiting
Clinical narrative: This case described the occurrence of vomiting in a 2 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine for prophylaxis. This report was received from the patient's mother and has not been verified by a physician or other health care professional. On 11/1/02, the patient received the 1st doses of diphtheria and tetanus toxoids and acellular pertussis vaccine, hepatitis B vaccine, 7-valent pneumococcal conjugate vaccine, Haemophilus influenzae type B conjugate vaccine, and inactivated poliomyelitis virus vaccine. On 11/2/02, one day post immunization, the patient experienced heavy vomiting with the inability to keep down fluids, lethargy, diarrhea and heavy urination. The patient was hospitalized for 7 days. The events resolved. The mother reported that the patient's physician considered the events to be caused by pertussis vaccine, and the partussis immunization series was discontinued. A 15-day follow report received 9/5/2003 adds: From additional correspondence received on 08/25/2003, the manufacturer ID number was provided (WAES0307USA03642). The pt's age was reported as 57 days. No new medically significant info was provided.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC, DTAP, HEP, HIBV, IPV, PNC
Symptoms: Diarrhoea, Lethargy, Pollakiuria, Vomiting
Clinical narrative: This case described the occurrence of vomiting in a 2 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine for prophylaxis. This report was received from the patient's mother and has not been verified by a physician or other health care professional. On 11/1/02, the patient received the 1st doses of diphtheria and tetanus toxoids and acellular pertussis vaccine, hepatitis B vaccine, 7-valent pneumococcal conjugate vaccine, Haemophilus influenzae type B conjugate vaccine, and inactivated poliomyelitis virus vaccine. On 11/2/02, one day post immunization, the patient experienced heavy vomiting with the inability to keep down fluids, lethargy, diarrhea and heavy urination. The patient was hospitalized for 7 days. The events resolved. The mother reported that the patient's physician considered the events to be caused by pertussis vaccine, and the partussis immunization series was discontinued. A 15-day follow report received 9/5/2003 adds: From additional correspondence received on 08/25/2003, the manufacturer ID number was provided (WAES0307USA03642). The pt's age was reported as 57 days. No new medically significant info was provided.
Age: 10.0
Sex: M
Vaccine: UNK
Symptoms: Autism
Clinical narrative: My son is diagnosed as autistic.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Balance disorder, Cough, Difficulty in walking, Dysphonia, Guillain-Barre syndrome
Clinical narrative: Transverse myelitis with progressive paraplegia. Pt developed numbness in left 4th and 5th toes 1-2 weeks after receiving the influenza vaccine in Nov 02. The numbness radiated down the lateral side of the left foot and the pt thought it was due to his boots. Within a few days he had similar symptoms in the right foot. The numbness progressed to the ankles in Dec 02, and then to the calves and by Jan 03 he experienced numbness from the knees down to the toes bilaterally. He had no associated pain, no tingling. He was able to walk but no longer able to run. He was in the process of changing duty, which delayed his seeking medical care. In March 03 he went to ER after the numbness progressed to the waist and he was occasionally losing his balance. He was seen by a PA and treated for gout. He followed up with the PA without improvement and was given a "stronger medicine" for gout. By the end of March he was seen in neurology and underwent "outpatient testing" but he did not receive the results. In mid-Apr 03 he awakened one morning and "my knees gave out from under me" and he fell to the floor. He was taken to the ER and was admitted to hospital for 2 weeks. He was diagnosed with Guillain-Barr syndrome and received IVIG on 4/18/03. He reports that he initially re-gained movement of the knees but that the improvement didn't last.  However, when he was transferred to rehabilitation hospital on May 1 03 he reports making steady improvement during the first few weeks and began to walk using a walker. However, a week before his scheduled discharge in mid-June he relapsed. Noteworthy medical history includes new onset cough and dry rash on the neck, chest, back, abdomen, arms and thighs in Feb 00 while in over-seas. He states the rash looked like ringworm and was treated with a cream after which it resolved. The cough was non-productive and continuous and was treated with inhalers. The cough lasted for 2 years the member reports. In Mar 00 intermittent hoarseness began. By Apr 00 the hoarseness became constant and on bro. Follow up on 10/28/2003: "Vaccine recipient did not recover from adverse events.  I have sent in an update on this patient already and we have determined that his condition is not vaccine-related.  He had neurologic complications of sarcoidosis.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Hypoaesthesia, Laboratory test abnormal, Paraplegia, Pyrexia, Rash
Clinical narrative: Transverse myelitis with progressive paraplegia. Pt developed numbness in left 4th and 5th toes 1-2 weeks after receiving the influenza vaccine in Nov 02. The numbness radiated down the lateral side of the left foot and the pt thought it was due to his boots. Within a few days he had similar symptoms in the right foot. The numbness progressed to the ankles in Dec 02, and then to the calves and by Jan 03 he experienced numbness from the knees down to the toes bilaterally. He had no associated pain, no tingling. He was able to walk but no longer able to run. He was in the process of changing duty, which delayed his seeking medical care. In March 03 he went to ER after the numbness progressed to the waist and he was occasionally losing his balance. He was seen by a PA and treated for gout. He followed up with the PA without improvement and was given a "stronger medicine" for gout. By the end of March he was seen in neurology and underwent "outpatient testing" but he did not receive the results. In mid-Apr 03 he awakened one morning and "my knees gave out from under me" and he fell to the floor. He was taken to the ER and was admitted to hospital for 2 weeks. He was diagnosed with Guillain-Barr syndrome and received IVIG on 4/18/03. He reports that he initially re-gained movement of the knees but that the improvement didn't last.  However, when he was transferred to rehabilitation hospital on May 1 03 he reports making steady improvement during the first few weeks and began to walk using a walker. However, a week before his scheduled discharge in mid-June he relapsed. Noteworthy medical history includes new onset cough and dry rash on the neck, chest, back, abdomen, arms and thighs in Feb 00 while in over-seas. He states the rash looked like ringworm and was treated with a cream after which it resolved. The cough was non-productive and continuous and was treated with inhalers. The cough lasted for 2 years the member reports. In Mar 00 intermittent hoarseness began. By Apr 00 the hoarseness became constant and on bro. Follow up on 10/28/2003: "Vaccine recipient did not recover from adverse events.  I have sent in an update on this patient already and we have determined that his condition is not vaccine-related.  He had neurologic complications of sarcoidosis.